The abstract is read at the publisher; the summary is JClub's.
CHCHD2 T61I worsens age-related brain pathology by disrupting the mitochondria–lysosome axis, linked to reduced cathepsin B and cathepsin L and impaired α-synuclein fibril clearance.
- Why it matters: CHCHD2 mutations are associated with Lewy body disorders, but the mechanisms connecting CHCHD2 dysfunction to age-driven proteostatic collapse and neurodegeneration were unclear.
- What they did: The study shows CHCHD2 T61I binds and lowers CTSB and CTSL, causing lysosomal membrane permeability and reducing α-synuclein fibril clearance, alongside human data showing CHCHD2 declines with age.
- The result: Wild-type CHCHD2 expression protects against age-related neuroinflammation, dopaminergic neuron loss, insoluble protein aggregation, and mitochondrial/lysosomal structural deterioration, and human LBD brains show reduced CTSB and CHCHD2.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.